1. INTRODUCTION 1.1. REPORT DESCRIPTION 1.2. RESEARCH METHODOLOGY 1.2.1 SECONDARY RESEARCH 1.2.2 DATA ANALYSIS FRAMEWORK 1.2.3 MARKET SIZE ESTIMATION 1.2.4 FORECASTING 1.2.5 PRIMARY RESEARCH AND DATA VALIDATION 2. MARKET SNAPSHOT, 2019-2030 MILLION USD 2.1. MARKET SNAPSHOT 3. PORTER’S FIVE FORCE MODEL ANALYSIS 4. MARKET DYNAMICS 4.1. GROWTH DRIVERS 4.1.1 DRIVER 1 4.1.2 DRIVER 2 4.1.3 DRIVER 3 4.1.4 DRIVER 4 4.2. CHALLENGES 4.2.1 CHALLENGE 1 4.2.2 CHALLENGE 2 4.3. OPPORTUNITIES 4.3.1 OPPORTUNITY 1 4.3.2 OPPORTUNITY 2 5. GLOBAL REGENERATIVE MEDICINE MARKET, BY PRODUCT TYPE 5.1. OVERVIEW 5.2. CELL THERAPY 5.2.1 CELL THERAPY MARKET, BY REGION 5.2.1.1 North America Cell Therapy Market, By Country 5.2.1.2 Europe Cell Therapy Market, By Country 5.2.1.3 Asia-Pacific Cell Therapy Market, By Country 5.2.1.4 Rest of World Cell Therapy Market, By Country 5.3. GENE THERAPY 5.3.1 GENE THERAPY MARKET, BY REGION 5.3.1.1 North America Gene Therapy Market, By Country 5.3.1.2 Europe Gene Therapy Market, By Country 5.3.1.3 Asia-Pacific Gene Therapy Market, By Country 5.3.1.4 Rest of World Gene Therapy Market, By Country 5.4. TISSUE ENGINEERING 5.4.1 TISSUE ENGINEERING MARKET, BY REGION 5.4.1.1 North America Tissue Engineering Market, By Country 5.4.1.2 Europe Tissue Engineering Market, By Country 5.4.1.3 Asia-Pacific Tissue Engineering Market, By Country 5.4.1.4 Rest of World Tissue Engineering Market, By Country 5.5. SMALL MOLECULE & BIOLOGIC 5.5.1 SMALL MOLECULE & BIOLOGIC MARKET, BY REGION 5.5.1.1 North America Small Molecule & Biologic Market, By Country 5.5.1.2 Europe Small Molecule & Biologic Market, By Country 5.5.1.3 Asia-Pacific Small Molecule & Biologic Market, By Country 5.5.1.4 Rest of World Small Molecule & Biologic Market, By Country 6. GLOBAL REGENERATIVE MEDICINE MARKET, BY MATERIAL 6.1. OVERVIEW 6.2. SYNTHETIC MATERIAL 6.2.1 GLOBAL SYNTHETIC MATERIAL MARKET, BY MATERIAL 6.2.1.1 Biodegradable Synthetic Polymers Market, By Region 6.2.1.1.1 North America Biodegradable Synthetic Polymers Market, By Country 6.2.1.1.2 Europe Biodegradable Synthetic Polymers Market, By Country 6.2.1.1.3 Asia-Pacific Biodegradable Synthetic Polymers Market, By Country 6.2.1.1.4 Rest of World Biodegradable Synthetic Polymers Market, By Country 6.2.1.2 Scaffold Market, By Region 6.2.1.2.1 North America Scaffold Market, By Country 6.2.1.2.2 Europe Scaffold Market, By Country 6.2.1.2.3 Asia-Pacific Scaffold Market, By Country 6.2.1.2.4 Rest of World Scaffold Market, By Country 6.2.1.3 Artificial Vascular Graft Materials Market, By Region 6.2.1.3.1 North America Artificial Vascular Graft Materials Market, By Country 6.2.1.3.2 Europe Artificial Vascular Graft Materials Market, By Country 6.2.1.3.3 Asia-Pacific Artificial Vascular Graft Materials Market, By Country 6.2.1.3.4 Rest of World Artificial Vascular Graft Materials Market, By Country 6.2.1.4 Hydrogel Material Market, By Region 6.2.1.4.1 North America Hydrogel Material Market, By Country 6.2.1.4.2 Europe Hydrogel Material Market, By Country 6.2.1.4.3 Asia-Pacific Hydrogel Material Market, By Country 6.2.1.4.4 Rest of World Hydrogel Material Market, By Country 6.2.2 SYNTHETIC MATERIAL MARKET, BY REGION 6.2.2.1 North America Synthetic Material Market, By Country 6.2.2.2 Europe Synthetic Material Market, By Country 6.2.2.3 Asia-Pacific Synthetic Material Market, By Country 6.2.2.4 Rest of World Synthetic Material Market, By Country 6.3. BIOLOGICALLY DERIVED MATERIAL 6.3.1 GLOBAL BIOLOGICALLY DERIVED MATERIAL MARKET, BY MATERIAL 6.3.1.1 Collagen Market, By Region 6.3.1.1.1 North America Collagen Market, By Country 6.3.1.1.2 Europe Collagen Market, By Country 6.3.1.1.3 Asia-Pacific Collagen Market, By Country 6.3.1.1.4 Rest of World Collagen Market, By Country 6.3.1.2 Xenogeneic Material Market, By Region 6.3.1.2.1 North America Xenogeneic Material Market, By Country 6.3.1.2.2 Europe Xenogeneic Material Market, By Country 6.3.1.2.3 Asia-Pacific Xenogeneic Material Market, By Country 6.3.1.2.4 Rest of World Xenogeneic Material Market, By Country 6.3.2 BIOLOGICALLY DERIVED MATERIAL MARKET, BY REGION 6.3.2.1 North America Biologically Derived Material Market, By Country 6.3.2.2 Europe Biologically Derived Material Market, By Country 6.3.2.3 Asia-Pacific Biologically Derived Material Market, By Country 6.3.2.4 Rest of World Biologically Derived Material Market, By Country 6.4. GENETICALLY ENGINEERED MATERIAL 6.4.1 GLOBAL GENETICALLY ENGINEERED MATERIAL MARKET, BY MATERIAL 6.4.1.1 Deoxyribonucleic Acid Transfection Vectors Market, By Region 6.4.1.1.1 North America Deoxyribonucleic Acid Transfection Vectors Market, By Country 6.4.1.1.2 Europe Deoxyribonucleic Acid Transfection Vectors Market, By Country 6.4.1.1.3 Asia-Pacific Deoxyribonucleic Acid Transfection Vectors Market, By Country 6.4.1.1.4 Rest of World Deoxyribonucleic Acid Transfection Vectors Market, By Country 6.4.1.2 Genetically Manipulated Cells Market, By Region 6.4.1.2.1 North America Genetically Manipulated Cells Market, By Country 6.4.1.2.2 Europe Genetically Manipulated Cells Market, By Country 6.4.1.2.3 Asia-Pacific Genetically Manipulated Cells Market, By Country 6.4.1.2.4 Rest of World Genetically Manipulated Cells Market, By Country 6.4.1.3 Three-dimensional Polymer Technology Market, By Region 6.4.1.3.1 North America Three-dimensional Polymer Technology Market, By Country 6.4.1.3.2 Europe Three-dimensional Polymer Technology Market, By Country 6.4.1.3.3 Asia-Pacific Three-dimensional Polymer Technology Market, By Country 6.4.1.3.4 Rest of World Three-dimensional Polymer Technology Market, By Country 6.4.1.4 Transgenics Market, By Region 6.4.1.4.1 North America Transgenics Market, By Country 6.4.1.4.2 Europe Transgenics Market, By Country 6.4.1.4.3 Asia-Pacific Transgenics Market, By Country 6.4.1.4.4 Rest of World Transgenics Market, By Country 6.4.1.5 Fibroblasts Market, By Region 6.4.1.5.1 North America Fibroblasts Market, By Country 6.4.1.5.2 Europe Fibroblasts Market, By Country 6.4.1.5.3 Asia-Pacific Fibroblasts Market, By Country 6.4.1.5.4 Rest of World Fibroblasts Market, By Country 6.4.1.6 Neural Stem Cells Market, By Region 6.4.1.6.1 North America Neural Stem Cells Market, By Country 6.4.1.6.2 Europe Neural Stem Cells Market, By Country 6.4.1.6.3 Asia-Pacific Neural Stem Cells Market, By Country 6.4.1.6.4 Rest of World Neural Stem Cells Market, By Country 6.4.1.7 Gene-activated Matrices Market, By Region 6.4.1.7.1 North America Gene-activated Matrices Market, By Country 6.4.1.7.2 Europe Gene-activated Matrices Market, By Country 6.4.1.7.3 Asia-Pacific Gene-activated Matrices Market, By Country 6.4.1.7.4 Rest of World Gene-activated Matrices Market, By Country 6.4.2 GENETICALLY ENGINEERED MATERIAL MARKET, BY REGION 6.4.2.1 North America Genetically Engineered Material Market, By Country 6.4.2.2 Europe Genetically Engineered Material Market, By Country 6.4.2.3 Asia-Pacific Genetically Engineered Material Market, By Country 6.4.2.4 Rest of World Genetically Engineered Material Market, By Country 7. GLOBAL REGENERATIVE MEDICINE MARKET, BY APPLICATION 7.1. OVERVIEW 7.2. CARDIOVASCULAR 7.2.1 CARDIOVASCULAR MARKET, BY REGION 7.2.1.1 North America Cardiovascular Market, By Country 7.2.1.2 Europe Cardiovascular Market, By Country 7.2.1.3 Asia-Pacific Cardiovascular Market, By Country 7.2.1.4 Rest of World Cardiovascular Market, By Country 7.3. ONCOLOGY 7.3.1 ONCOLOGY MARKET, BY REGION 7.3.1.1 North America Oncology Market, By Country 7.3.1.2 Europe Oncology Market, By Country 7.3.1.3 Asia-Pacific Oncology Market, By Country 7.3.1.4 Rest of World Oncology Market, By Country 7.4. DERMATOLOGY 7.4.1 DERMATOLOGY MARKET, BY REGION 7.4.1.1 North America Dermatology Market, By Country 7.4.1.2 Europe Dermatology Market, By Country 7.4.1.3 Asia-Pacific Dermatology Market, By Country 7.4.1.4 Rest of World Dermatology Market, By Country 7.5. MUSCULOSKELETAL 7.5.1 MUSCULOSKELETAL MARKET, BY REGION 7.5.1.1 North America Musculoskeletal Market, By Country 7.5.1.2 Europe Musculoskeletal Market, By Country 7.5.1.3 Asia-Pacific Musculoskeletal Market, By Country 7.5.1.4 Rest of World Musculoskeletal Market, By Country 7.6. WOUND HEALING 7.6.1 WOUND HEALING MARKET, BY REGION 7.6.1.1 North America Wound Healing Market, By Country 7.6.1.2 Europe Wound Healing Market, By Country 7.6.1.3 Asia-Pacific Wound Healing Market, By Country 7.6.1.4 Rest of World Wound Healing Market, By Country 7.7. OPHTHALMOLOGY 7.7.1 OPHTHALMOLOGY MARKET, BY REGION 7.7.1.1 North America Ophthalmology Market, By Country 7.7.1.2 Europe Ophthalmology Market, By Country 7.7.1.3 Asia-Pacific Ophthalmology Market, By Country 7.7.1.4 Rest of World Ophthalmology Market, By Country 7.8. NEUROLOGY 7.8.1 NEUROLOGY MARKET, BY REGION 7.8.1.1 North America Neurology Market, By Country 7.8.1.2 Europe Neurology Market, By Country 7.8.1.3 Asia-Pacific Neurology Market, By Country 7.8.1.4 Rest of World Neurology Market, By Country 7.9. OTHERS 7.9.1 OTHERS MARKET, BY REGION 7.9.1.1 North America Others Market, By Country 7.9.1.2 Europe Others Market, By Country 7.9.1.3 Asia-Pacific Others Market, By Country 7.9.1.4 Rest of World Others Market, By Country 8. GLOBAL REGENERATIVE MEDICINE MARKET, BY REGION 8.1. OVERVIEW 8.2. NORTH AMERICA 8.2.1 NORTH AMERICA REGENERATIVE MEDICINE MARKET, BY PRODUCT TYPE 8.2.2 NORTH AMERICA REGENERATIVE MEDICINE MARKET, BY MATERIAL 8.2.2.1 North America Synthetic Material Market, By Material 8.2.2.2 North America Biologically Derived Material Market, By Material 8.2.2.3 North America Genetically Engineered Material Market, By Material 8.2.2.4 North America Pharmaceutical Market, By Material 8.2.3 NORTH AMERICA REGENERATIVE MEDICINE MARKET, BY APPLICATION 8.2.4 NORTH AMERICA REGENERATIVE MEDICINE, MARKET BY COUNTRY 8.2.4.1 U.S. 8.2.4.1.1 U.S. Regenerative Medicine Market, By Product Type 8.2.4.1.2 U.S. Regenerative Medicine Market, By Material 8.2.4.1.2.1. U.S. Synthetic Material Market, By Material 8.2.4.1.2.2. U.S. Biologically Derived Material Market, By Material 8.2.4.1.2.3. U.S. Genetically Engineered Material Market, By Material 8.2.4.1.2.4. U.S. Pharmaceutical Market, By Material 8.2.4.1.3 U.S. Regenerative Medicine Market, By Application 8.2.4.2 Canada 8.2.4.2.1 Canada Regenerative Medicine Market, By Product Type 8.2.4.2.2 Canada Regenerative Medicine Market, By Material 8.2.4.2.2.1. Canada Synthetic Material Market, By Material 8.2.4.2.2.2. Canada Biologically Derived Material Market, By Material 8.2.4.2.2.3. Canada Genetically Engineered Material Market, By Material 8.2.4.2.2.4. Canada Pharmaceutical Market, By Material 8.2.4.2.3 Canada Regenerative Medicine Market, By Application 8.2.4.3 Mexico 8.2.4.3.1 Mexico Regenerative Medicine Market, By Product Type 8.2.4.3.2 Mexico Regenerative Medicine Market, By Material 8.2.4.3.2.1. Mexico Synthetic Material Market, By Material 8.2.4.3.2.2. Mexico Biologically Derived Material Market, By Material 8.2.4.3.2.3. Mexico Genetically Engineered Material Market, By Material 8.2.4.3.2.4. Mexico Pharmaceutical Market, By Material 8.2.4.3.3 Mexico Regenerative Medicine Market, By Application 8.3. EUROPE 8.3.1 EUROPE REGENERATIVE MEDICINE MARKET, BY PRODUCT TYPE 8.3.2 EUROPE REGENERATIVE MEDICINE MARKET, BY MATERIAL 8.3.2.1 Europe Synthetic Material Market, By Material 8.3.2.2 Europe Biologically Derived Material Market, By Material 8.3.2.3 Europe Genetically Engineered Material Market, By Material 8.3.2.4 Europe Pharmaceutical Market, By Material 8.3.3 EUROPE REGENERATIVE MEDICINE MARKET, BY APPLICATION 8.3.4 EUROPE REGENERATIVE MEDICINE, MARKET BY COUNTRY 8.3.4.1 UK 8.3.4.1.1 UK Regenerative Medicine Market, By Product Type 8.3.4.1.2 UK Regenerative Medicine Market, By Material 8.3.4.1.2.1. UK Synthetic Material Market, By Material 8.3.4.1.2.2. UK Biologically Derived Material Market, By Material 8.3.4.1.2.3. UK Genetically Engineered Material Market, By Material 8.3.4.1.2.4. UK Pharmaceutical Market, By Material 8.3.4.1.3 UK Regenerative Medicine Market, By Application 8.3.4.2 France 8.3.4.2.1 France Regenerative Medicine Market, By Product Type 8.3.4.2.2 France Regenerative Medicine Market, By Material 8.3.4.2.2.1. France Synthetic Material Market, By Material 8.3.4.2.2.2. France Biologically Derived Material Market, By Material 8.3.4.2.2.3. France Genetically Engineered Material Market, By Material 8.3.4.2.2.4. France Pharmaceutical Market, By Material 8.3.4.2.3 France Regenerative Medicine Market, By Application 8.3.4.3 Germany 8.3.4.3.1 Germany Regenerative Medicine Market, By Product Type 8.3.4.3.2 Germany Regenerative Medicine Market, By Material 8.3.4.3.2.1. Germany Synthetic Material Market, By Material 8.3.4.3.2.2. Germany Biologically Derived Material Market, By Material 8.3.4.3.2.3. Germany Genetically Engineered Material Market, By Material 8.3.4.3.2.4. Germany Pharmaceutical Market, By Material 8.3.4.3.3 Germany Regenerative Medicine Market, By Application 8.3.4.4 Italy 8.3.4.4.1 Italy Regenerative Medicine Market, By Product Type 8.3.4.4.2 Italy Regenerative Medicine Market, By Material 8.3.4.4.2.1. Italy Synthetic Material Market, By Material 8.3.4.4.2.2. Italy Biologically Derived Material Market, By Material 8.3.4.4.2.3. Italy Genetically Engineered Material Market, By Material 8.3.4.4.2.4. Italy Pharmaceutical Market, By Material 8.3.4.4.3 Italy Regenerative Medicine Market, By Application 8.3.4.5 Spain 8.3.4.5.1 Spain Regenerative Medicine Market, By Product Type 8.3.4.5.2 Spain Regenerative Medicine Market, By Material 8.3.4.5.2.1. Spain Synthetic Material Market, By Material 8.3.4.5.2.2. Spain Biologically Derived Material Market, By Material 8.3.4.5.2.3. Spain Genetically Engineered Material Market, By Material 8.3.4.5.2.4. Spain Pharmaceutical Market, By Material 8.3.4.5.3 Spain Regenerative Medicine Market, By Application 8.3.4.6 Russia 8.3.4.6.1 Russia Regenerative Medicine Market, By Product Type 8.3.4.6.2 Russia Regenerative Medicine Market, By Material 8.3.4.6.2.1. Russia Synthetic Material Market, By Material 8.3.4.6.2.2. Russia Biologically Derived Material Market, By Material 8.3.4.6.2.3. Russia Genetically Engineered Material Market, By Material 8.3.4.6.2.4. Russia Pharmaceutical Market, By Material 8.3.4.6.3 Russia Regenerative Medicine Market, By Application 8.3.4.7 Rest of Europe 8.3.4.7.1 Rest of Europe Regenerative Medicine Market, By Product Type 8.3.4.7.2 Rest of Europe Regenerative Medicine Market, By Material 8.3.4.7.2.1. Rest of Europe Synthetic Material Market, By Material 8.3.4.7.2.2. Rest of Europe Biologically Derived Material Market, By Material 8.3.4.7.2.3. Rest of Europe Genetically Engineered Material Market, By Material 8.3.4.7.2.4. Rest of Europe Pharmaceutical Market, By Material 8.3.4.7.3 Rest of Europe Regenerative Medicine Market, By Application 8.4. ASIA-PACIFIC 8.4.1 ASIA-PACIFIC REGENERATIVE MEDICINE MARKET, BY PRODUCT TYPE 8.4.2 ASIA-PACIFIC REGENERATIVE MEDICINE MARKET, BY MATERIAL 8.4.2.1 Asia-Pacific Synthetic Material Market, By Material 8.4.2.2 Asia-Pacific Biologically Derived Material Market, By Material 8.4.2.3 Asia-Pacific Genetically Engineered Material Market, By Material 8.4.2.4 Asia-Pacific Pharmaceutical Market, By Material 8.4.3 ASIA-PACIFIC REGENERATIVE MEDICINE MARKET, BY APPLICATION 8.4.4 ASIA-PACIFIC REGENERATIVE MEDICINE, MARKET BY COUNTRY 8.4.4.1 China 8.4.4.1.1 China Regenerative Medicine Market, By Product Type 8.4.4.1.2 China Regenerative Medicine Market, By Material 8.4.4.1.2.1. China Synthetic Material Market, By Material 8.4.4.1.2.2. China Biologically Derived Material Market, By Material 8.4.4.1.2.3. China Genetically Engineered Material Market, By Material 8.4.4.1.2.4. China Pharmaceutical Market, By Material 8.4.4.1.3 China Regenerative Medicine Market, By Application 8.4.4.2 India 8.4.4.2.1 India Regenerative Medicine Market, By Product Type 8.4.4.2.2 India Regenerative Medicine Market, By Material 8.4.4.2.2.1. India Synthetic Material Market, By Material 8.4.4.2.2.2. India Biologically Derived Material Market, By Material 8.4.4.2.2.3. India Genetically Engineered Material Market, By Material 8.4.4.2.2.4. India Pharmaceutical Market, By Material 8.4.4.2.3 India Regenerative Medicine Market, By Application 8.4.4.3 Japan 8.4.4.3.1 Japan Regenerative Medicine Market, By Product Type 8.4.4.3.2 Japan Regenerative Medicine Market, By Material 8.4.4.3.2.1. Japan Synthetic Material Market, By Material 8.4.4.3.2.2. Japan Biologically Derived Material Market, By Material 8.4.4.3.2.3. Japan Genetically Engineered Material Market, By Material 8.4.4.3.2.4. Japan Pharmaceutical Market, By Material 8.4.4.3.3 Japan Regenerative Medicine Market, By Application 8.4.4.4 Australia 8.4.4.4.1 Australia Regenerative Medicine Market, By Product Type 8.4.4.4.2 Australia Regenerative Medicine Market, By Material 8.4.4.4.2.1. Australia Synthetic Material Market, By Material 8.4.4.4.2.2. Australia Biologically Derived Material Market, By Material 8.4.4.4.2.3. Australia Genetically Engineered Material Market, By Material 8.4.4.4.2.4. Australia Pharmaceutical Market, By Material 8.4.4.4.3 Australia Regenerative Medicine Market, By Application 8.4.4.5 South Korea 8.4.4.5.1 South Korea Regenerative Medicine Market, By Product Type 8.4.4.5.2 South Korea Regenerative Medicine Market, By Material 8.4.4.5.2.1. South Korea Synthetic Material Market, By Material 8.4.4.5.2.2. South Korea Biologically Derived Material Market, By Material 8.4.4.5.2.3. South Korea Genetically Engineered Material Market, By Material 8.4.4.5.2.4. South Korea Pharmaceutical Market, By Material 8.4.4.5.3 South Korea Regenerative Medicine Market, By Application 8.4.4.6 Taiwan 8.4.4.6.1 Taiwan Regenerative Medicine Market, By Product Type 8.4.4.6.2 Taiwan Regenerative Medicine Market, By Material 8.4.4.6.2.1. Taiwan Synthetic Material Market, By Material 8.4.4.6.2.2. Taiwan Biologically Derived Material Market, By Material 8.4.4.6.2.3. Taiwan Genetically Engineered Material Market, By Material 8.4.4.6.2.4. Taiwan Pharmaceutical Market, By Material 8.4.4.6.3 Taiwan Regenerative Medicine Market, By Application 8.4.4.7 Rest of Asia-Pacific 8.4.4.7.1 Rest of Asia-Pacific Regenerative Medicine Market, By Product Type 8.4.4.7.2 Rest of Asia-Pacific Regenerative Medicine Market, By Material 8.4.4.7.2.1. Rest of Asia-Pacific Synthetic Material Market, By Material 8.4.4.7.2.2. Rest of Asia-Pacific Biologically Derived Material Market, By Material 8.4.4.7.2.3. Rest of Asia-Pacific Genetically Engineered Material Market, By Material 8.4.4.7.2.4. Rest of Asia-Pacific Pharmaceutical Market, By Material 8.4.4.7.3 Rest of Asia-Pacific Regenerative Medicine Market, By Application 8.5. REST OF WORLD 8.5.1 REST OF WORLD REGENERATIVE MEDICINE MARKET, BY PRODUCT TYPE 8.5.2 REST OF WORLD REGENERATIVE MEDICINE MARKET, BY MATERIAL 8.5.2.1 Rest of World Synthetic Material Market, By Material 8.5.2.2 Rest of World Biologically Derived Material Market, By Material 8.5.2.3 Rest of World Genetically Engineered Material Market, By Material 8.5.2.4 Rest of World Pharmaceutical Market, By Material 8.5.3 REST OF WORLD REGENERATIVE MEDICINE MARKET, BY APPLICATION 8.5.4 REST OF WORLD REGENERATIVE MEDICINE, MARKET BY COUNTRY 8.5.4.1 Brazil 8.5.4.1.1 Brazil Regenerative Medicine Market, By Product Type 8.5.4.1.2 Brazil Regenerative Medicine Market, By Material 8.5.4.1.2.1. Brazil Synthetic Material Market, By Material 8.5.4.1.2.2. Brazil Biologically Derived Material Market, By Material 8.5.4.1.2.3. Brazil Genetically Engineered Material Market, By Material 8.5.4.1.2.4. Brazil Pharmaceutical Market, By Material 8.5.4.1.3 Brazil Regenerative Medicine Market, By Application 8.5.4.2 Turkey 8.5.4.2.1 Turkey Regenerative Medicine Market, By Product Type 8.5.4.2.2 Turkey Regenerative Medicine Market, By Material 8.5.4.2.2.1. Turkey Synthetic Material Market, By Material 8.5.4.2.2.2. Turkey Biologically Derived Material Market, By Material 8.5.4.2.2.3. Turkey Genetically Engineered Material Market, By Material 8.5.4.2.2.4. Turkey Pharmaceutical Market, By Material 8.5.4.2.3 Turkey Regenerative Medicine Market, By Application 8.5.4.3 Venezuela 8.5.4.3.1 Venezuela Regenerative Medicine Market, By Product Type 8.5.4.3.2 Venezuela Regenerative Medicine Market, By Material 8.5.4.3.2.1. Venezuela Synthetic Material Market, By Material 8.5.4.3.2.2. Venezuela Biologically Derived Material Market, By Material 8.5.4.3.2.3. Venezuela Genetically Engineered Material Market, By Material 8.5.4.3.2.4. Venezuela Pharmaceutical Market, By Material 8.5.4.3.3 Venezuela Regenerative Medicine Market, By Application 8.5.4.4 Saudi Arabia 8.5.4.4.1 Saudi Arabia Regenerative Medicine Market, By Product Type 8.5.4.4.2 Saudi Arabia Regenerative Medicine Market, By Material 8.5.4.4.2.1. Saudi Arabia Synthetic Material Market, By Material 8.5.4.4.2.2. Saudi Arabia Biologically Derived Material Market, By Material 8.5.4.4.2.3. Saudi Arabia Genetically Engineered Material Market, By Material 8.5.4.4.2.4. Saudi Arabia Pharmaceutical Market, By Material 8.5.4.4.3 Saudi Arabia Regenerative Medicine Market, By Application 8.5.4.5 South Africa 8.5.4.5.1 South Africa Regenerative Medicine Market, By Product Type 8.5.4.5.2 South Africa Regenerative Medicine Market, By Material 8.5.4.5.2.1. South Africa Synthetic Material Market, By Material 8.5.4.5.2.2. South Africa Biologically Derived Material Market, By Material 8.5.4.5.2.3. South Africa Genetically Engineered Material Market, By Material 8.5.4.5.2.4. South Africa Pharmaceutical Market, By Material 8.5.4.5.3 South Africa Regenerative Medicine Market, By Application 8.5.4.6 Remaining Countries 8.5.4.6.1 Remaining Countries Regenerative Medicine Market, By Product Type 8.5.4.6.2 Remaining Countries Regenerative Medicine Market, By Material 8.5.4.6.2.1. Remaining Countries Synthetic Material Market, By Material 8.5.4.6.2.2. Remaining Countries Biologically Derived Material Market, By Material 8.5.4.6.2.3. Remaining Countries Genetically Engineered Material Market, By Material 8.5.4.6.2.4. Remaining Countries Pharmaceutical Market, By Material 8.5.4.6.3 Remaining Countries Regenerative Medicine Market, By Application 9. COMPANY PROFILES 9.1. ACELITY HOLDINGS, INC. 9.1.1 COMPANY OVERVIEW 9.1.2 COMPANY SNAPSHOT 9.1.3 OPERATING BUSINESS SEGMENTS 9.1.4 PRODUCT PORTFOLIO 9.1.5 BUSINESS PERFORMANCE 9.1.6 KEY STRATEGIC MOVES AND DEVELOPMENT 9.2. ATHERSYS, INC. 9.2.1 COMPANY OVERVIEW 9.2.2 COMPANY SNAPSHOT 9.2.3 OPERATING BUSINESS SEGMENTS 9.2.4 PRODUCT PORTFOLIO 9.2.5 BUSINESS PERFORMANCE 9.2.6 KEY STRATEGIC MOVES AND DEVELOPMENT 9.3. CRYOLIFE, INC. 9.3.1 COMPANY OVERVIEW 9.3.2 COMPANY SNAPSHOT 9.3.3 OPERATING BUSINESS SEGMENTS 9.3.4 PRODUCT PORTFOLIO 9.3.5 BUSINESS PERFORMANCE 9.3.6 KEY STRATEGIC MOVES AND DEVELOPMENT 9.4. INTEGRA LIFESCIENCES CORPORATION 9.4.1 COMPANY OVERVIEW 9.4.2 COMPANY SNAPSHOT 9.4.3 OPERATING BUSINESS SEGMENTS 9.4.4 PRODUCT PORTFOLIO 9.4.5 BUSINESS PERFORMANCE 9.4.6 KEY STRATEGIC MOVES AND DEVELOPMENT 9.5. ISTO BIOLOGICS 9.5.1 COMPANY OVERVIEW 9.5.2 COMPANY SNAPSHOT 9.5.3 OPERATING BUSINESS SEGMENTS 9.5.4 PRODUCT PORTFOLIO 9.5.5 BUSINESS PERFORMANCE 9.5.6 KEY STRATEGIC MOVES AND DEVELOPMENT 9.6. MEDTRONIC PLC 9.6.1 COMPANY OVERVIEW 9.6.2 COMPANY SNAPSHOT 9.6.3 OPERATING BUSINESS SEGMENTS 9.6.4 PRODUCT PORTFOLIO 9.6.5 BUSINESS PERFORMANCE 9.6.6 KEY STRATEGIC MOVES AND DEVELOPMENT 9.7. ORGANOGENESIS INC. 9.7.1 COMPANY OVERVIEW 9.7.2 COMPANY SNAPSHOT 9.7.3 OPERATING BUSINESS SEGMENTS 9.7.4 PRODUCT PORTFOLIO 9.7.5 BUSINESS PERFORMANCE 9.7.6 KEY STRATEGIC MOVES AND DEVELOPMENT 9.8. STRYKER CORPORATION 9.8.1 COMPANY OVERVIEW 9.8.2 COMPANY SNAPSHOT 9.8.3 OPERATING BUSINESS SEGMENTS 9.8.4 PRODUCT PORTFOLIO 9.8.5 BUSINESS PERFORMANCE 9.8.6 KEY STRATEGIC MOVES AND DEVELOPMENT 9.9. U.S. STEM CELL, INC. 9.9.1 COMPANY OVERVIEW 9.9.2 COMPANY SNAPSHOT 9.9.3 OPERATING BUSINESS SEGMENTS 9.9.4 PRODUCT PORTFOLIO 9.9.5 BUSINESS PERFORMANCE 9.9.6 KEY STRATEGIC MOVES AND DEVELOPMENT 9.10. ZIMMER BIOMET HOLDINGS, INC. 9.10.1 COMPANY OVERVIEW 9.10.2 COMPANY SNAPSHOT 9.10.3 OPERATING BUSINESS SEGMENTS 9.10.4 PRODUCT PORTFOLIO 9.10.5 BUSINESS PERFORMANCE 9.10.6 KEY STRATEGIC MOVES AND DEVELOPMENT